Skip to main content
Journal cover image

239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study

Publication ,  Conference
Nebhan, C; Cortellini, A; Ma, W; Ganta, T; Song, H; Ye, F; Irlmeier, R; Debnath, N; Saeed, A; Radford, M; Alahmadi, A; Diamond, A; Hoimes, C ...
Published in: Journal for ImmunoTherapy of Cancer
November 2021

Duke Scholars

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

November 2021

Volume

9

Issue

Suppl 2

Start / End Page

A257 / A257

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nebhan, C., Cortellini, A., Ma, W., Ganta, T., Song, H., Ye, F., … Naqash, A. R. (2021). 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In Journal for ImmunoTherapy of Cancer (Vol. 9, pp. A257–A257). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.239
Nebhan, Caroline, Alessio Cortellini, Weijie Ma, Teja Ganta, Haocan Song, Fei Ye, Rebecca Irlmeier, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” In Journal for ImmunoTherapy of Cancer, 9:A257–A257. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, et al. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In: Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A257–A257.
Nebhan, Caroline, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” Journal for ImmunoTherapy of Cancer, vol. 9, no. Suppl 2, BMJ, 2021, pp. A257–A257. Crossref, doi:10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley C, Owen D, Alaiwi SA, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman T, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Bello MGD, Kalofonou F, Daniels E, Ascierto P, Pinato D, Choueiri T, Johnson D, Marron T, Wang Y, Naqash AR. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A257–A257.
Journal cover image

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

November 2021

Volume

9

Issue

Suppl 2

Start / End Page

A257 / A257

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology